N. Agrawal, “An institution-based non-randomised prospective study to estimate the efficacy and adverse effect profile of apremilast for moderate to severe refractory palmoplantar psoriasis”, Int J Res Dermatol, vol. 9, no. 3, pp. 111–116, Apr. 2023.